Unicystic ameloblastoma in an infant: a management dilemma

Ariel Israel Hirschhorn1, Marilena Vered, Amos Buchner

  • 1Department of Oral and Maxillofacial Surgery (Head: Prof. Dr. Shlomo Taicher), The Chaim Sheba Medical Center, Tel Hashomer, Israel.

Insights

Conservative management of a rare unicystic ameloblastoma in an infant avoided surgery, prioritizing mandibular growth and tooth development. Ongoing monitoring shows no recurrence in this youngest reported patient.

Area of Science:

  • Oral and Maxillofacial Surgery
  • Pediatric Dentistry
  • Oncology

Background:

  • Unicystic ameloblastoma is a rare odontogenic tumor, with the mural subtype presenting unique management challenges, especially in pediatric patients.
  • Early surgical intervention in infants can impede critical mandibular growth and dental development.

Observation:

  • A 10-month-old female presented with a rare unicystic ameloblastoma (mural subtype), the youngest documented case.
  • Conservative management was chosen over immediate aggressive surgery to preserve facial and dental development.

Findings:

  • The patient was managed conservatively with close monitoring and a plan for delayed surgical intervention if recurrence occurred.
  • At 3.5 years old, the patient shows no evidence of tumor recurrence, indicating successful conservative management.

Implications:

  • Conservative, non-surgical management may be a viable option for unicystic ameloblastoma in very young children.
  • Prioritizing growth and development through watchful waiting can lead to favorable outcomes, reducing the need for extensive surgical procedures in infants.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...